Mesenchymal stem cells (MSCs) are multipotent non-hematopoietic cells capable of differentiating into hepatocytes. Valproic acid (VPA), a histone deacetylase inhibitor, has recently exhibited profound therapeutic activity in preclinical tumor test. A research group in China investigated the induction of hepatic differentiation of mouse bone marrow MSCs (mBM-MSCs) by VPA. Direct evidences have been shown that the usefulness of VPA in the trans-differentiation of mBM-MSCs into hepatocytes both in vitro and in vivo.
Read »Navigation
User login
Visit the BiotechMashup Blog
Best upcoming scoops - Health
- Adolescent Binge Drinking Leads to Changes in Alcohol Drinking, Anxiety, and Amygdalar Corticotropin Releasing Factor Cells in A
- High school students test best with 7 hours of sleep at night
- 'Explorers,' who embrace the uncertainty of choices, use specific part of cortex
- New prenatal genetic test is much more powerful at detecting fetal abnormalities
- Research finds ways that young couples experience less relationship stress, higher satisfaction